Jump Financial’s BioAtla BCAB Stock Holding History

Jump Financial’s Portfolio BCAB Stock Details BCAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-936	Closed	-$125K	–	1795
2023 Q1	$125K	Buy	+936	New	+$169K	0.01%	1406
2022 Q3	–	Sell	-308	Closed	-$44K	–	1590
2022 Q2	$44K	Sell	308 -502	-62%	-$79.9K	﹤0.01%	1511
2022 Q1	$203K	Buy	810 +262	+48%	+$110K	0.01%	1295
2021 Q4	$538K	Buy	548 +27	+5%	+$34.5K	0.03%	620
2021 Q3	$767K	Buy	521 +289	+125%	+$563K	0.06%	358
2021 Q2	$491K	Buy	+232	New	+$524K	0.05%	481

Other funds holding BCAB

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jump Financial's BCAB Position: Q2 2023 in Review

Jump Financial sold out of BioAtla (BCAB) in Q2 2023, closing a stake of 936 shares — an estimated $125K sold.

Jump Financial first reported a position in BCAB in Q2 2021 and held it in 6 quarters. The position peaked at $767K in Q3 2021. 87 funds tracked by Wall St. Rank hold BCAB as of Q2 2023.

Jump Financial reported no remaining BioAtla position as of Q2 2023 after selling out during the quarter.
Jump Financial sold 936 BioAtla shares in Q2 2023, an estimated $125K.
Jump Financial first reported a position in BioAtla in Q2 2021 and held it in 6 quarters.
Jump Financial's BioAtla position peaked at $767K in Q3 2021.
87 funds tracked by Wall St. Rank held BioAtla as of Q2 2023.

Based on Jump Financial's 13F filing for Q2 2023, filed 7 Aug 2023.